These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9008951)

  • 41. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination.
    Hussain Z; Das BC; Husain SA; Murthy NS; Kar P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):689-93. PubMed ID: 16677154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunization against hepatitis A during an outbreak in a Jewish Orthodox community--Quebec, 1997-1998.
    Deshaies D; Dion R; Valiquette L; Auger N
    Can Commun Dis Rep; 1998 Sep; 24(18):145-51. PubMed ID: 9780447
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute hepatitis A in a traveler who had received preexposure inactivated hepatitis A virus vaccine.
    Kurup A; San LM; Yew WS
    Clin Infect Dis; 1999 Jun; 28(6):1324-5. PubMed ID: 10451178
    [No Abstract]   [Full Text] [Related]  

  • 45. [Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver].
    Bruguera M; Buti M; Diago M; García Bengoechea M; Jara P; Pedreira JA; Ruiz Extremera A
    Gastroenterol Hepatol; 1997 Nov; 20(9):467-73. PubMed ID: 9445743
    [No Abstract]   [Full Text] [Related]  

  • 46. [Statement of the Advisory Committee on Immunizations of Sociedad Chilena de Infectología about outbreaks of hepatitis A in Chile].
    Villena R; Wilhelm J; Calvo X; Cerda J; Escobar C; Moreno G; Veliz L; Potin M
    Rev Chilena Infectol; 2017 Aug; 34(4):371-373. PubMed ID: 29165515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of hepatitis A/B vaccine versus hepatitis B vaccine in public sexually transmitted disease clinics.
    Jacobs RJ; Meyerhoff AS
    Sex Transm Dis; 2003 Nov; 30(11):859-65. PubMed ID: 14603096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Recommendations for the use of the hepatitis A vaccine in day care centers. Committee on Vaccines of the Spanish Pediatric Society and Spanish Association for the Study of the Liver].
    Gastroenterol Hepatol; 1998; 21(7):346-51. PubMed ID: 9808900
    [No Abstract]   [Full Text] [Related]  

  • 49. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy.
    Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN
    Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Prevalence of anti-hepatitis A in patients with chronic liver disease].
    Diago M; Luján M; García V; Cors R; Carbonell P; Tuset C; Gimeno J
    Gastroenterol Hepatol; 1998; 21(7):324-6. PubMed ID: 9808894
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [For whom is the hepatitis A vaccination in 1995?].
    Buisson Y
    Gastroenterol Clin Biol; 1995 Oct; 19(10):745-6. PubMed ID: 8566554
    [No Abstract]   [Full Text] [Related]  

  • 54. Characteristics of epidemic hepatitis A in Baltimore City: implications for control measures.
    Stone S; Erickson B; Alexander M; Dunning R; Israel E; Dwyer DM
    Md Med J; 1993 Oct; 42(10):995-1000. PubMed ID: 8259051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Natural history of viral hepatitis A in Chilean adults: clinical and laboratory aspects].
    Ibarra H; Riedemann S; Froesner G; Reinhardt G; Gómez JC; Cornejo A; Toledo C; Soto N; Ruiz M
    G E N; 1993; 47(1):25-31. PubMed ID: 8243969
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatitis A. A health paradox].
    Domínguez Carmona M
    An R Acad Nac Med (Madr); 1993; 110(2):243-74; discussion 275-82. PubMed ID: 8311198
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost-benefit of mass prophylaxis with immune serum globulin to control waterborne hepatitis A: a case study.
    Egoz N
    Isr J Med Sci; 1986; 22(3-4):277-82. PubMed ID: 3091532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Should hepatitis A vaccination be routinely given to children?
    Schoub BD; Blackburn NK; Martin DJ; McAnerney JM; Sim JG
    S Afr Med J; 1999 Oct; 89(10):1074-5. PubMed ID: 10582062
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis A vaccination: should we routinely vaccinate children?
    Bender WJ
    S D J Med; 2000 Jul; 53(7):269-70. PubMed ID: 10932608
    [No Abstract]   [Full Text] [Related]  

  • 60. [Geographical distribution of physicians in Chile].
    Goic A
    Rev Med Chil; 1995 Mar; 123(3):306-11. PubMed ID: 8525169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.